Full Name
Mikael Hartman
Variants
Hartman, M
Hartman, M.
Hartman, Mikael
Hartman M.
 
Main Affiliation
 
 
Email
ephbamh@nus.edu.sg
 

Refined By:
Subject:  Female
Subject:  Adult
Subject:  Humans
Date Issued:  [2010 TO 2019]

Results 1-6 of 6 (Search time: 0.011 seconds).

Issue DateTitleAuthor(s)
12018Determinants of breast size in Asian womenLim L.Y.; Ho P.J. ; Liu J. ; Chay W.Y. ; Tan M.-H.; Hartman M. ; Li J. 
22018Determinants of satisfaction with cosmetic outcome in breast cancer survivors: A cross-sectional studyHo P.J. ; Hartman M. ; Young-Afat D.A.; Gernaat S.A.M.; Lee S.C.; Verkooijen H.M.
32016High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancerWang, T ; Srivastava, S ; Hartman, M ; Buhari, S.A ; Chan, C.-W ; Iau, P; Khin, L.W ; Wong, A ; Tan, S.-H ; Goh, B.-C ; Lee, S.-C 
42016Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancerWong A.L.A. ; Sundar R.; Wang T.-T. ; Ng T.-C. ; Zhang B. ; Tan S.-H. ; Soh T.I.P.; Pang A.S.L.; Tan C.-S.; Ow S.G.W.; Wang L. ; Mogro J.; Ho J.; Jeyasekharan A.D. ; Huang Y.; Thng C.-H. ; Chan C.-W. ; Hartman M. ; Iau P.; Buhari S.A. ; Goh B.-C. ; Lee S.-C. 
52016Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathwayWang, T ; Seah, S ; Loh, X ; Chan, C.-W ; Hartman, M ; Goh, B.-C ; Lee, S.-C 
62016The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from SwedenSackey, H; Hui, M ; Czene, K; Verkooijen, H; Edgren, G; Frisell, J; Hartman, M